Breton, who is in charge of immunization policy against the SARS-CoV-2 coronavirus at the European Commission, said so in statements issued on Saturday by the German Der Spiegel magazine, reproduced here by TASS news agency.
He noted that Sputnik V ‘will simply arrive too late’ to meet the EU’s goal of having the entire population vaccinated by summer. ‘The European Medicines Agency will study Sputnik V and make a correct assessment. I am convinced of that,’ Breton stated.
However, he clarified that approval does not mean that the vaccine can be produced in sufficient quantities. He expressed that even in a normal situation, it would take many months before it would be possible to establish and launch adequate production.
A few weeks ago, the European Commissioner assured that the EU did not need Sputnik-V vaccine, when asked about the possibility of using the drug to compensate for shortages in the EU bloc.
Breton commented that the European Commission does not doubt the quality of the drug, but knows that Russia ‘also has difficulties with the production of this vaccine.’
In that regard, Russia’s President Vladimir Putin ensured that Russia does not impose its drugs on anyone, but such statements from the EU make one think that European officials defend the interests of individual companies, not fellow citizens, the head of State stressed.